Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Marianne Ulcickas Yood

Datos Biográficos

ID5540945
NOMBREMarianne Ulcickas Yood
NOMBRESMarianne Ulcickas
APELLIDOYood
FIRMAYOOD M U
AFILIACIONESHenry Ford Health System
ORCID0000-0003-4204-0871
VERIFICADONo
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2004
AÑO MÁS RECIENTE DE PUBLICACIÓN2014
ÍNDICE H0
  • Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

    Larry A Allen, Marianne Ulcickas Yood et al.•ARTICLE•Medical Care•2014•Referencias: 3

    BACKGROUND: Cardiotoxicity is a known complication of certain breast cancer therapies, but rates come from clinical trials with design features that limit external validity. The ability to accurately identify cardiotoxicity from administrative data would enhance safety information. OBJECTIVE: To characterize the performance of clinical coding algorithms for identification of cardiac dysfunction in a cancer population. RESEARCH DESIGN: We sampled …

  • Use of Guideline Recommended Follow-Up Care in Cancer Survivors

    Gregory S Cooper, Christine Cole Johnson et al.•ARTICLE•Medical Care•2006•Referencias: 16

    BACKGROUND: After potentially curative cancer treatment, patients may receive procedures for routine monitoring for recurrence or for evaluation of symptoms or signs. OBJECTIVE: We sought to characterize surveillance care guideline-recommended and other procedures performed in cancer survivors according to routine versus diagnostic indications. METHODS: This was a retrospective cohort study of paper and electronic medical records between 1990 and…

  • Potential Drug–Drug Interactions in the Outpatient Setting

    Jennifer Elston Lafata, Lonni Schultz et al.•ARTICLE•Medical Care•2006•Referencias: 40

    BACKGROUND: Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern. OBJECTIVE: We estimate the frequency of potentially interacting concomitant medication dispensing among outpatients. RESEARCH DESIGN: We report the number and percent of patients annually dispensed an object drug of interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with a potentiall…

  • Routine Surveillance Care After Cancer Treatment With Curative Intent

    Jennifer Elston Lafata, Jan Simpkins et al.•ARTICLE•Medical Care•2005•Referencias: 16

    BACKGROUND: Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations. METHODS: Cohorts of patients aged 30 years or older diagnosed with breast, colorectal, endometrial, lung, or prostate cancer between 1990 and 1995 and treated with curative intent were identified (n = 100 per site). Receipt and indications for examinations and p…

  • Treatment and Referral Patterns for Colorectal Cancer

    Susan A Oliveria, Marianne Ulcickas Yood et al.•ARTICLE•Medical Care•2004•Referencias: 28

    BACKGROUND: National guidelines recommend adjuvant chemotherapy for colorectal cancer stages III, and IV; however, it has been shown that only 45-55% of these patients receive chemotherapy. OBJECTIVES: We sought to describe treatment patterns for patients diagnosed with colorectal cancer and to examine the reasons why patients do not receive chemotherapy. RESEARCH DESIGN: This was a retrospective cohort study. SETTING AND PATIENTS: Patients inclu…

Sin obras prominentes en esta página.

  • Treatment and Referral Patterns for Colorectal Cancer

    Susan A Oliveria, Marianne Ulcickas Yood et al.•ARTICLE•Medical Care•2004•Referencias: 28

    BACKGROUND: National guidelines recommend adjuvant chemotherapy for colorectal cancer stages III, and IV; however, it has been shown that only 45-55% of these patients receive chemotherapy. OBJECTIVES: We sought to describe treatment patterns for patients diagnosed with colorectal cancer and to examine the reasons why patients do not receive chemotherapy. RESEARCH DESIGN: This was a retrospective cohort study. SETTING AND PATIENTS: Patients inclu…

  • Routine Surveillance Care After Cancer Treatment With Curative Intent

    Jennifer Elston Lafata, Jan Simpkins et al.•ARTICLE•Medical Care•2005•Referencias: 16

    BACKGROUND: Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations. METHODS: Cohorts of patients aged 30 years or older diagnosed with breast, colorectal, endometrial, lung, or prostate cancer between 1990 and 1995 and treated with curative intent were identified (n = 100 per site). Receipt and indications for examinations and p…

  • Use of Guideline Recommended Follow-Up Care in Cancer Survivors

    Gregory S Cooper, Christine Cole Johnson et al.•ARTICLE•Medical Care•2006•Referencias: 16

    BACKGROUND: After potentially curative cancer treatment, patients may receive procedures for routine monitoring for recurrence or for evaluation of symptoms or signs. OBJECTIVE: We sought to characterize surveillance care guideline-recommended and other procedures performed in cancer survivors according to routine versus diagnostic indications. METHODS: This was a retrospective cohort study of paper and electronic medical records between 1990 and…

  • Potential Drug–Drug Interactions in the Outpatient Setting

    Jennifer Elston Lafata, Lonni Schultz et al.•ARTICLE•Medical Care•2006•Referencias: 40

    BACKGROUND: Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern. OBJECTIVE: We estimate the frequency of potentially interacting concomitant medication dispensing among outpatients. RESEARCH DESIGN: We report the number and percent of patients annually dispensed an object drug of interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with a potentiall…

  • Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

    Larry A Allen, Marianne Ulcickas Yood et al.•ARTICLE•Medical Care•2014•Referencias: 3

    BACKGROUND: Cardiotoxicity is a known complication of certain breast cancer therapies, but rates come from clinical trials with design features that limit external validity. The ability to accurately identify cardiotoxicity from administrative data would enhance safety information. OBJECTIVE: To characterize the performance of clinical coding algorithms for identification of cardiac dysfunction in a cancer population. RESEARCH DESIGN: We sampled …

Internal Medicine (5 obras) · Internal Medicine (5 obras) · Medicine (5 obras) · Cancer (4 obras) · Colorectal cancer (3 obras) · Emergency Medicine (3 obras) · Emergency Medicine (3 obras) · Global Cancer Incidence and Screening (3 obras) · Intensive care medicine (3 obras) · Medical record (3 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae